Half-Life Cancer Research Results
Half-Life, Half-Life: Click to Expand ⟱
| Source: |
| Type: |
For many drugs, the half-life is the time it takes for half of the drug’s active substance to be eliminated from the bloodstream.
In medicine, knowing a drug’s half-life helps in designing treatment regimens that reduce adverse effects.
|
Obesity, Obesity: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Arthritis, |
NA |
|
|
|
- |
Review, |
Obesity, |
NA |
|
|
|
*AntiCan↑, *TRPV1↑, *cardioP↑, AntiCan↓, Apoptosis↑, ChemoSen↑, *Inflam↓, *Pain↓, *AntiAg↑, *Weight↓, *BioAv↑, BioAv↑, Half-Life↝, Half-Life↓,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Cell Death ⓘ
Apoptosis↑, 1,
Drug Metabolism & Resistance ⓘ
BioAv↑, 1, ChemoSen↑, 1, Half-Life↓, 1, Half-Life↝, 1,
Functional Outcomes ⓘ
AntiCan↓, 1,
Total Targets: 6
Pathway results for Effect on Normal Cells:
Cell Death ⓘ
TRPV1↑, 1,
Migration ⓘ
AntiAg↑, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↑, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, cardioP↑, 1, Pain↓, 1, Weight↓, 1,
Total Targets: 8
Scientific Paper Hit Count for: Half-Life, Half-Life
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:63 Cells:% prod#:% Target#:1109 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page